Summary
For Year 2026-27, Suraksha Diagnostic reports the following shareholding: Total Promoters at 49.1%, Mutual Fund at 19.79%, Insurance at 0%, Foreign Institutional Investors at 13.46%, Domestic Institutional Investors at 3.35%, and Retail at 14.31%. This breakdown provides a quick snapshot of ownership distribution for Suraksha Diagnostic in 2026-27.
Suraksha Diagnostic FAQs
As of 04-2026, the promoter shareholding in Suraksha Diagnostic stands at 49.1% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Suraksha Diagnostic is 13.46% and 3.35% respectively.
The retail shareholding of the Suraksha Diagnostic is 14.31%.
Changes in shareholding patterns of Suraksha Diagnostic can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Suraksha Diagnostic are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
